See also this year's filing and all EDGAR filings for this company.
PDF Report 0001333248_2012_Cadence_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001333248, Cadence Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 132,929,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 13,433,000 |
| 2 | PropertyPlantAndEquipmentNet | 10,569,000 |
| 3 | remainder_Assets | 7,229,000 |
| 4 | LiabilitiesCurrent | 16,037,000 |
| 5 | LiabilitiesNoncurrent | 28,813,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 81,504,000 |
| 9 | ResearchAndDevelopmentExpense | 8,885,000 |
| 10 | remainder_Expenses | 15,049,000 |
| 11 | remainder_Revenues | 16,696,000 |
| 12 | remainder_NetIncome | -4,279,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 164,160,000 |
| 1 | Liabilities | 44,850,000 |
| 2 | Expenses | 105,438,000 |
| 3 | Revenues | 16,696,000 |
| 4 | StockholdersEquity | 119,310,000 |
| 5 | NetIncome | -93,021,000 |
| 6 | ComprehensiveNetIncome | -93,021,000 |
| 7 | BaseVar | 167,711,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.60 |
| 9 | EconomicCapitalRatio | 2.75 |
Edgar->Model Mapping
Feature Distribution
